Systemic Bio Opens State-of-the-Art Laboratory for Bioprinted Organ-on-a-Chip R&D, Production to Accelerate Drug Discovery & Development

Systemic Bio Opens State-of-the-Art Laboratory for Bioprinted Organ-on-a-Chip R&D, Production to Accelerate Drug Discovery & Development

HOUSTON, TX, USA, Apr 7, 2023 – Systemic Bio, a 3D Systems (NYSE:DDD) company, announced the opening of its new headquarters for hydrogel scaffold manufacturing and organ-on-a-chip R&D to facilitate its mission to accelerate drug discovery and development. This state-of-the-art facility contains a cleanroom for bioprinted hydrogel production and is located in the TMC Innovation Factory […]